How old is your brain? Take our FREE brain age test! Specially developed for those over 45!

CONDITIONS A-Z

Scientists develop a new, inexpensive way to predict Alzheimer's

Your brain's capacity for information is a reliable predictor of Alzheimer's disease and can be cheaply and easily tested, according to scientists.

In Europe, it is estimated that one in every 20 people over the age of 65 has Alzheimer's disease and the numbers are predicted to double in Western Europe and treble in Eastern Europe by 2040.1

"We have developed a low-cost behavioral assessment that can clue someone in to Alzheimer's disease at its earliest stage," said Michael Wenger, associate professor of psychology at Penn State. "By examining (information) processing capacity, we can detect changes in the progression of mild cognitive impairment (MCI)."

MCI is a condition that affects language, memory and related mental functions. It is distinct from the ordinary mental degradation associated with aging and is a likely precursor to the more serious Alzheimer's disease. Both MCI and Alzheimer's are linked to a steady decline in the volume of the hippocampus, the area of the brain responsible for long term memory and spatial reasoning.

MRIs -- magnetic resonance imaging -- are the most reliable and direct way to detect hippocampal atrophy and diagnose MCI. But for many, the procedure is unavailable or too expensive.

"MRIs can cost hundreds of dollars an hour," Wenger said. "We created a much cheaper alternative, based on a memory test, that correlates with hippocampal degradation." Wenger and his collaborators at the Mayo Clinic College of Medicine, Rochester, Minn., detail their findings in the current issue of the Journal of Mathematical Psychology.

From a computer model of an atrophying hippocampus, the researchers determined how to estimate capacity with a statistical measure of how quickly tasks are completed. Applying this analysis to a memory test for people with MCI, the researchers were able to gauge their hippocampal capacity and compare it to the progression of their ailment.

"My collaborators at the Mayo Clinic backed up this study with MRIs for the MCI group," Wenger said. "These capacity measures we developed showed a reliable relationship to the hippocampal volume measurements, so we know we are on the right track."

The scientists began by modeling the hippocampus as a complex electrical circuit. Equations governing electric current and voltage mimicked the electrical firing of neurons within the circuit. The researchers switched off neurons in the simulation to model atrophy of the hippocampus.

With fewer cells available to process electrical signals, the model hippocampus slowed down, but its capacity for processing information decreased at an even faster rate. Capacity was the most sensitive measure of how the hippocampus was deteriorating, more than the average processing speed.

"We then applied this to the gold standard of the field -- the Free and Cued Selective Reminding Test (FCSRT)," Wenger said. "This is a test that can discriminate between normal age-related memory changes and changes caused by impairment."

The researchers gave this test to five groups of participants: college students, healthy middle-aged adults, healthy elderly individuals, people with diagnosed cases of MCI and a control group of age-matched individuals without MCI. The first three groups each had 100 members and the last two each had 50.

During the FCSRT, the researchers showed the participants descriptive words, such as "part of the body" and "artery," and asked the participants to choose the picture that fit these cues from a set of 24 images, in this case, a picture of a heart. The psychologists then asked the subjects to recall as many items as they could. For objects they failed to remember, the psychologists provided the category cues, providing more information and testing the limits of the subjects' capacity.

The researchers analyzed the response times for the tasks and the number of items that were recalled, with and without additional cues. The MCI group showed the greatest sensitivity to added cues -- the additional input either substantially helped or inhibited their performance. But like the computer model, estimates of capacity highlighted the greatest cognitive difference between the MCI group and the others.

This study's approach to defining processing capacity is unusual. The scientists combined disparate principles of engineering and statistics, mathematically translating processing capacity into what is called the "hazard function."

The hazard function is well known in engineering, but relatively new for fields like psychology. It gives the probability that a task that is not yet completed will be completed in the next interval of time.

By measuring how long it takes a participant to recall the objects during the FCSRT, the psychologists fit a model based on the hazard function to each participant and obtain a measure of his or her capacity for the memorization task.

The difference in hazard function measures between the MCI group and all other groups was statistically much more pronounced than the differences between all groups in the number of items they recalled. These hazard function differences also outweighed the contrasts between all groups in their response times. The hazard function model proved to be the most sensitive diagnostic for cognitive distinctions in the groups, making it a reliable indicator of capacity and a better signal of the underlying hippocampal atrophy than processing speed alone.

The researchers' results are valid for every person, not just for the whole group. Since the modified FCSRT relies on personal reaction times, hazard analysis and performance, it can track the progression of MCI for anyone, anywhere there is access to a computer.

"These results are still preliminary, but very encouraging," Wenger said. "We plan to study what this approach can tell us about mental impairments related to other conditions, like iron deficiencies, in the future."

Wenger worked with Selamawit Negash, neurology research fellow, Ronald C. Peterson, professor of neurology, and Lyndsay Peterson, research associate, all at the Mayo Clinic College of Medicine.

The National Institute on Aging provided funding for this project.

About Alzheimer's Disease

Alzheimer's disease is a progressive, degenerative disease of the brain which causes thinking and memory to become seriously impaired.2 It is the most common form of dementia and is named after the German physician Alois Alzheimer who first identified the condition in 1906.3 Alois Alzheimer described the appearance of 'tangles' and 'plaques' which have since been found to be caused by a build-up of proteins in the brain and play a part in its deterioration.3

Alzheimer's disease gradually affects the ability of the brain to function properly, causing the loss of intellectual and social abilities severe enough to interfere with daily functioning.4 This happens because nerve cells, in certain areas of the brain which control a person's mental abilities, start to deteriorate and die. The reason this happens is not fully known, but may be due to the build up of plaques and tangles in the brain.

_______________________________________________________________

Article Source:

Adapted from materials provided by Penn State.

Additional References:

[1] Alzheimer Europe. Who Cares? The state of dementia care in Europe. Luxembourg: Alzheimer Europe; 2006; Available to purchase from URL: http://www.alzheimer-europe.org/Publications/Alzheimer-Europe-Reports. Last accessed January 2010.

[2] Alzheimer Society of Canada. What is Alzheimer's Disease? Introduction. Alzheimer Society of Canada website. Available at URL: http://www.alzheimer.ca/english/disease/whatisit-intro.htm. Last updated March 2009. Last accessed February 2010

[3] Alzheimer's Association. What is Alzheimer's? Available at URL: http://www.alz.org/alzheimers_disease_what_is_alzheimers.asp. Last updated 18 February 2010. Last accessed February 2010.

[4] Mayo Clinic. Alzheimer's disease definition. Available at URL: http://www.mayoclinic.com/health/alzheimers-disease/DS00161. Last updated 17 January 2009. Last accessed February 2010.

_______________________________________________________________

Related Pages:

NEWS
It’s off to school for sickly kids It’s off to school for sickly kids
Fever, diarrhoea or vomiting is not enou ....
Help take the hassle out of daily injections Help take the hassle out of daily injections
In the following video TV's Dr Christian ....
The Seven Habits of Highly Effective People The Seven Habits of Highly Effective People
The book “The Seven Habits of Highly E ....
Natural pain relief that mimics medicinal marijuana Natural pain relief that mimics medicinal marijuana
A newly discovered molecular mechanism h ....
Gum disease linked with Alzheimer's Disease Gum disease linked with Alzheimer's Disease
Gum disease may increase the risk of cog ....
FEATURES
Save your pet from diabetes Save your pet from diabetes
You can help your pets stay diabetes fre ....
Diet and Lifestyle Tips to Help Prevent Cancer Diet and Lifestyle Tips to Help Prevent Cancer
There are more than 293,000 new cases of ....
Is food really making you ill? Is food really making you ill?
Our daily diet is regularly blamed for c ....
The Healing Power of Food The Healing Power of Food
The immune system is a complex and fanta ....
Benefits of Meditation and How to Get Started Benefits of Meditation and How to Get Started
More and more of us are learning to medi ....
MOST READ

Expert Medical Blogs

Latest Articles